Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Net Debt / EBITDA

Apellis Pharmaceuticals Inc Net Debt / EBITDA Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Net Debt / EBITDA from 2019 to 2019. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
Other Ratios Metrics:
  • Apellis Pharmaceuticals Inc Total Debt / Capital for the quarter ending September 09, 2018 was $12m a -24.67% decrease of -3m year over year
  • Apellis Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -57.45% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Total Debt / Equity for the quarter ending September 09, 2018 was $14m a -29.04% decrease of -4m year over year
View Chart On Koyfin